|
Volume 270,
Number 13,
Issue of March 31, 1995 pp. 7213-7218
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Transcriptional
Down-regulation of m2 Muscarinic Receptor Gene Expression in Human
Embryonic Lung (HEL 299) Cells by Protein Kinase C
(Received for publication, December 19, 1994)
Jonathan
Rousell ,
El-Bdaoui
Haddad,
Judith C. W.
Mak ,
Peter J.
Barnes
m2 muscarinic receptor gene expression was investigated
following stimulation of protein kinase C (PKC) with the phorbol ester
4 -phorbol dibutyrate (PDBu) in HEL 299 cells. PDBu (100
nM) caused a time-dependent decrease in the steady-state
levels of m2 receptor mRNA and in specific
[ H]N-methyl-scopolamine binding.
Preincubation with the PKC inhibitor GF-109203X inhibited the reduction
in M receptor and mRNA levels induced by PDBu, confirming
the involvement of PKC. Chronic PDBu treatment also caused
desensitization of the receptor as forskolin-stimulated cAMP
accumulation, inhibited by carbachol in control cells, was lost upon
treatment with PDBu for 24 h. Co-incubation with PDBu and the protein
synthesis inhibitor cycloheximide, inhibited PDBu-mediated reduction of
m2 receptor mRNA, indicating new protein synthesis is required for
down-regulation. Half-life studies using the transcriptional inhibitor
actinomycin D suggested that the stability of the m2 receptor mRNA was
not altered by PDBu treatment (t = 2 h).
Nuclear run-on assays showed a 50% reduction in the rate of m2 receptor
gene transcription after treatment with PDBu for 12 h. In conclusion we
have provided evidence for heterologous regulation of m2 receptor gene
expression through changes in gene transcription resulting in
uncoupling of M receptors. Furthermore, the synthesis of an
unidentified factor is required for the down-regulation process.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-C. Hsieh and J. Papaconstantinou
Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice
FASEB J,
February 1, 2006;
20(2):
259 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-X. Zhang, C.-K. Yeh, T. K. Hymer, M. D. Lifschitz, and M. S. Katz
EGF inhibits muscarinic receptor-mediated calcium signaling in a human salivary cell line
Am J Physiol Cell Physiol,
October 1, 2000;
279(4):
C1024 - C1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-B. Haddad, A. J. Fox, J. Rousell, G. Burgess, P. McIntyre, P. J. Barnes, and K. F. Chung
Post-Transcriptional Regulation of Bradykinin B1 and B2 Receptor Gene Expression in Human Lung Fibroblasts by Tumor Necrosis Factor-alpha : Modulation by Dexamethasone
Mol. Pharmacol.,
June 1, 2000;
57(6):
1123 - 1131.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Bergmann, P. J. Barnes, and R. Newton
Molecular Regulation of Granulocyte Macrophage Colony-Stimulating Factor in Human Lung Epithelial Cells by Interleukin (IL)-1beta , IL-4, and IL-13 Involves Both Transcriptional and Post-Transcriptional Mechanisms
Am. J. Respir. Cell Mol. Biol.,
May 1, 2000;
22(5):
582 - 589.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Newton, J. Seybold, L. M. E. Kuitert, M. Bergmann, and P. J. Barnes
Repression of Cyclooxygenase-2 and Prostaglandin E2 Release by Dexamethasone Occurs by Transcriptional and Post-transcriptional Mechanisms Involving Loss of Polyadenylated mRNA
J. Biol. Chem.,
November 27, 1998;
273(48):
32312 - 32321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Lee and R. L. Malek
Nerve Growth Factor Regulation of m4 Muscarinic Receptor mRNA Stability but Not Gene Transcription Requires Mitogen-activated Protein Kinase Activity
J. Biol. Chem.,
August 28, 1998;
273(35):
22317 - 22325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Li, V. A. Vaidya, J. D. Alvaro, P. A. Iredale, R. Hsu, G. Hoffman, L. Fitzgerald, P. K. Curran, C. A. Machida, P. H. Fishman, et al.
Protein Kinase C-Mediated Down-Regulation of beta 1-Adrenergic Receptor Gene Expression in Rat C6 Glioma Cells
Mol. Pharmacol.,
July 1, 1998;
54(1):
14 - 21.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Rousell, E.-B. Haddad, M. A. Lindsay, and P. J. Barnes
Regulation of m2 Muscarinic Receptor Gene Expression by Platelet-Derived Growth Factor: Involvement of Extracellular Signal-Regulated Protein Kinases in the Down-Regulation Process
Mol. Pharmacol.,
December 1, 1997;
52(6):
966 - 973.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Souaze, W. Rostene, and P. Forgez
Neurotensin Agonist Induces Differential Regulation of Neurotensin Receptor mRNA. IDENTIFICATION OF DISTINCT TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL MECHANISMS
J. Biol. Chem.,
April 11, 1997;
272(15):
10087 - 10094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Martin, S. B. Kertesy, and G. R. Dubyak
Down-Regulation of P2U-Purinergic Nucleotide Receptor Messenger RNA Expression During In Vitro Differentiation of Human Myeloid Leukocytes by Phorbol Esters or Inflammatory Activators
Mol. Pharmacol.,
January 1, 1997;
51(1):
97 - 108.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E.-B. Haddad, J. Rousell, M. A. Lindsay, and P. J. Barnes
Synergy between Tumor Necrosis Factor alpha and Interleukin 1beta in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression. INVOLVEMENT OF PROTEIN KINASE A AND CERAMIDE PATHWAYS
J. Biol. Chem.,
December 20, 1996;
271(51):
32586 - 32592.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|